U. S.
SECURITIES AND EXCHANGE COMMISSION


WASHINGTON,
D. C. 20549





FORM
10-Q





x QUARTERLY REPORT UNDER
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934





For the
quarterly period ended December 31, 2009





o TRANSITION REPORT UNDER
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934





For the
transition period from _____ to _____





Commission
File No. 0-50863





INOLIFE
TECHNOLOGIES INC.





(Name of
Registrant in its Charter)





NEW
      YORK
              
              30-0592474(State
      or Other Jurisdiction of
              
              (I.R.S.
      Employerincorporation
      or organization)
              
              Identification
      No.)





6040-A
135 SIX FORKS ROAD, RALEIGH, NC 27609





(Address
of Principal Executive Offices)





Issuer's
Telephone Number: 919-727-9186





Indicate
by check mark whether the Registrant (1) has filed all reports required to be
filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the Registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.   Yes x No o





Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files.)





Yes o No x





Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of "large accelerated filer," "accelerated filer" and "smaller
reporting company" in Rule 12b-2 of the Exchange Act. (Check One)





Large
      accelerated filer o
            Accelerated
      filer oNon-accelerated
      filer   o
            Small
      reporting company x





Indicate
by check mark whether the Registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes o No x




APPLICABLE
ONLY TO CORPORATE ISSUERS: Indicate the number of shares outstanding of each of
the Registrant's classes of common stock, as of the latest practicable date:
February 2, 2010 Common Voting Stock: 102,412,041 shares.





TABLE OF CONTENTS




PagePART
      I - FINANCIAL INFORMATIONItem
      1.  Financial Statements.
              2Item
      2.  Management's Discussion and Analysis of Financial Condition
      and Results of Operations.
              8Item
      3.  Quantitative and Qualitative Disclosures About Market
      Risk.
              10Item
      4.  Controls and Procedures.
              10PART
      II - OTHER INFORMATIONItem
      1.  Legal Proceedings.
              11Item
      2.  Unregistered Sales of Equity Securities and Use of
      Proceeds.
              11Item
      3.  Defaults Upon Senior Securities.
              11Item
      4.  Submission of Matters to a Vote of Security
      Holders.
              11Item
      5.  Other Information.
              11Item
      6.  Exhibits.
              11





PART
I. FINANCIAL INFORMATION





Item
1.             Financial
Statements


INOLIFE
TECHNOLOGIES, INC.


BALANCE
SHEETS




12/31/09(Unaudited)ASSETSCurrent
      AssetsCash
      and Cash Equivalents
                  
                  $
                  28,083TOTAL
      ASSETS
                  
                  $
                  28,083LIABILITIES
      & STOCKERHOLDERS' EQUITY (DEFICIT)Current
      LiabilitiesAccounts
      Payable
                  
                  
                  71,358Accrued
      Expenses
                  
                  
                  -Bridge
      Loan Payable
                  
                  
                  55,000Loans
      Payable-Management
                  
                  
                  49,194Loans
      Payable-Shareholder
                  
                  
                  102,250Payroll
      Tax Liabilities
                  
                  
                  14,211Total
      Current Liabilities
                  
                  
                  292,013Total
      Liabilities
                  
                  
                  292,013Stockholders'
      Equity (Deficit)Common
      Stock:  $.01 Par, 250,000,000 Authorized 102,412,041 Shares
      Issued and Outstanding as of December 31, 2009 and
                  
                  
                  1,024,120Shares
      held in Escrow
                  
                  
                  (250,000
                  )Additional
      Paid In Capital
                  
                  
                  -Accumulated
      Deficit
                  
                  
                  (1,038,050
                  )Total
      Stockholders' Equity (Deficit)
                  
                  
                  (263,930
                  )TOTAL
      LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)
                  
                  $
                  28,083





The
accompanying notes are an integral part of these financial
statements.


2


INOLIFE
TECHNOLOGIES, INC.


STATEMENTS
OF OPERATIONS


(A
DEVELOPMENT STAGE COMPANY)


THREE
MONTHS ENDED DECEMBER 31, 2009 AND FROM DATE OF INCEPTION




Three months Ended
                        December 31, 2009
                      
                      
                      From Inception (6/17/09) to
                        December 31, 2009(Unaudited)
                      
                      
                      (Unaudited)REVENUES
                      
                      $
                      -
                      
                      
                      
                      -EXPENSESAdvertising
                      
                      
                      11,300
                      
                      
                      
                      11,300Consulting
      Services
                      
                      
                      240,000
                      
                      
                      
                      257,600Office
      Expense
                      
                      
                      539
                      
                      
                      
                      539Professional
      Services
                      
                      
                      10,820
                      
                      
                      
                      12,820Rent
                      
                      
                      6,138
                      
                      
                      
                      6,138Travel
      Expense
                      
                      
                      564
                      
                      
                      
                      564Total
      Expense
                      
                      
                      269,361
                      
                      
                      
                      288,961Loss
      from Operations
                      
                      
                      (269,361
                      )
                      
                      
                      (288,961
                      )Other
      Income / (Expense)Gain
      on Loan forgiveness
                      
                      
                      10,501
                      
                      
                      
                      10,501Recapitalization
      Expenses
                      
                      
                      
                      
                      
                      
                      (759,590
                      )NET
      INCOME (LOSS)
                      
                      $
                      (258,860
                      )
                      
                      $
                      (1,038,050
                      )PROFIT
      PER SHARE:Basic
                      
                      $
                      (0.0033
                      )Fully
      Diluted
                      
                      $
                      (0.0033
                      )WEIGHTED
      ADVERAGE COMMONSHARES
      OUTSTANDING:Basic
                      
                      
                      79,251,547Fully
      Diluted
                      
                      
                      79,251,547





The
accompanying notes are an integral part of these financial
statements.


3


INOLIFE
TECHNOLOGIES, INC. (FORMERLY NEXXNOW, INC.)


STATEMENTS
OF CASH FLOWS


(
A DEVELOPMENT STAGE COMPANY)


PERIOD
ENDED DECEMBER 31, 2009 AND FROM DATE OF INCEPTION




December 31, 2009
                    
                    
                    From Inception (6/17/09)
                      to December 31, 2009(Unaudited)
                    
                    
                    (Unaudited)CHANGES
      IN ASSETS AND LIABILITIESNet
      Income (Loss)
                    
                    $
                    (1,038,050
                    )
                    
                    $
                    (1,038,050
                    )NON-CASH
      ADJUSTMENTSCommon
      Stock issued in exchange for services
                    
                    
                    240,000
                    
                    
                    
                    240,000Gain
      on Debt Forgiveness
                    
                    
                    (10,501
                    )
                    
                    
                    (10,501
                    )Loss
      on Recapitalization
                    
                    
                    759,590
                    
                    
                    
                    759,590Cash
      Flows from Operating ActivitiesAccounts
      Payable
                    
                    
                    (20,241
                    )
                    
                    
                    (20,241
                    )Accrued
      Expenses
                    
                    
                    (1,250
                    )
                    
                    
                    (1,250
                    )Payroll
      Tax Liabilities
                    
                    
                    -
                    
                    
                    
                    -Net
      cash provided by Operating Activities
                    
                    
                    (70,452
                    )
                    
                    
                    (70,452
                    )Cash
      Flows from Financing ActivitiesProceeds
      of Loans from shareholders
                    
                    
                    98,535
                    
                    
                    
                    98,535Net
      cash provided by Financing Activities
                    
                    
                    98,535
                    
                    
                    
                    98,535NET
      CHANGE IN CASH AND CASH EQUIVALENTS
                    
                    
                    28,083
                    
                    
                    
                    28,083CASH
      AND CASH EQUIVALENTS -BEGINNING OF PERIOD
                    
                    
                    -
                    
                    
                    
                    -CASH
      AND CASH EQUIVALENTS - END OF PERIOD
                    
                    $
                    28,083
                    
                    
                    $
                    28,083Income
      Taxes and Interest Paid
                    
                    $
                    -
                    
                    
                    $
                    -SUPPLEMENTAL
      DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIESCommon
      Stock issued in Satisfaction of Notes Payable
                    
                    $
                    7,000
                    
                    
                    $
                    7,000





The
accompanying notes are an integral part of these financial
statements.


4


NOTES
TO FINANCIAL STATEMENTS





NOTE
A - THE COMPANY





History





InoLife
Technologies, Inc. formerly NexxNow, Inc., (“The Company”) was incorporated
under the laws of the State of New York on November 12, 1998 as Safe Harbour
Health Care Properties, Ltd.  In July 2004, the Company changed its
name to Centale, Inc.  The Company was engaged in the business of
leasing real estate to health care facilities.  During 1999, the
Company ceased its operations and commenced actions to voluntarily seek
protection from creditors under the bankruptcy code.  During 2003, the
Company distributed its assets to the creditors in satisfaction of its
outstanding liabilities.  The bankruptcy was subsequently
dismissed.  The Company remained dormant until 2004, when one of the
Company's shareholders purchased a controlling interest.  In February
2004, the Company began its development stage as an internet based marketing
company. The development stage ended during the fiscal year ended March 31,
2006.  The Company, as of December 2007 discontinued its internet
marketing due to difficulties with service providers and subsequent
cancellations by customers.





In 2008,
the Company changed its name to NexxNow, Inc.





The
Company consummated a business combination with InoVet,
Ltd.(“InoVet”),   which has been accounted for as a
recapitalization of the InoVet. The business combination resulted in the
issuance of 59,419,448 shares of common stock which has been retroactively
presented in the statement of stockholders’ equity.





Effective
July 29, 2009, the majority shareholder of NexxNow, Inc. entered into an
agreement for the purchase of common stock with Gary Berthold, the current
President/Chief Executive Office of the Company.  In accordance with
the agreement, the majority shareholder sold an aggregate of 35,013,540 shares
of restricted common stock of the Company representing an equity interest of
approximately 70.8%.





Effective
as of September 1, 2009, the Board of Directors of the Company changed the name
from Nexxnow, Inc. to InoLife Technologies Inc.





Effective
September 17, 2009 the Board of Directors of the Company authorized the
execution of a share exchange agreement with Inovet, Ltd., and the shareholders
of Inovet, Ltd.  In accordance with the agreement the Company agreed
to: (i) acquire all of the issued and outstanding shares of common stock of
Inovet from the Inovet Shareholders; and (ii) issue an aggregate of 10,000,000
shares of its restricted common stock to the Inovet
Shareholders


5


NOTE
B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES





Method
of Accounting





The
financial statements of InoLife Technologies, Inc. (Formerly NexxNow, Inc.) (The
"Company" included herein) have been prepared by the Company pursuant to the
rules and regulations of the Security Exchange Commission (the
"SEC").  The financial statements reflect the transactions of InoVet,
Ltd, the accounting acquirer.  The Company maintains its books and
prepares its financial statements on the accrual basis of
accounting.





The
accompanying consolidated financial statements reflect all adjustments of a
normal and recurring nature which are, in the opinion of management, necessary
to present fairly the financial position, results of operations and cash flows
of the Company as of and for the period ended December 31,
2009.  Factors that affect the comparability of financial data from
year to year include nonrecurring expenses associated with the Company's
registration with the SEC, costs incurred to raise capital and stock
awards.





Cash
and Cash Equivalents





Cash and
cash equivalents include time deposits, certificates of deposits and all highly
liquid debt instruments with original maturities of three months or less. The
Company maintains cash and cash equivalents at financial institutions, which
periodically may exceed federally insured amounts.





Income
Taxes





The
Company accounts for income taxes in accordance with FASB ASC 740 (Prior
Authoritative Literature: Financial Accounting Standards Board Statement of
Financial Accounting Standards (“SFAS”) No. 109), “Accounting For Income Taxes”
using the asset and liability approach, which requires recognition of deferred
tax liabilities and assets for the expected future tax consequences of temporary
differences between the carrying amounts and the tax basis of such assets and
liabilities.  This method utilizes enacted statutory tax rates in
effect for the year in which the temporary differences are expected to reverse
and gives immediate effect to changes in the income tax rates upon
enactment.  Deferred tax assets are recognized, net of any valuation
allowance, for temporary differences and net operating loss and tax credit carry
forwards.  Deferred income tax expense represents the change in net
deferred assets and liability balances.  The Company had no material
deferred tax assets or liabilities for the period presented.  Deferred
income taxes result from temporary differences between the basis of assets and
liabilities recognized for differences between the financial statement and tax
basis thereon, and for the expected future benefits to be derived from net
operating losses and tax credit carry forwards.  The Company has had
significant operating losses and a valuation allowance is recorded for the
entire amount of the deferred tax assets.  There are no open tax
periods.





Earnings
Per Share





Earnings
(loss) per common share is computed in accordance with FASB ASC 260 (Prior
Authoritative Literature: Financial Accounting Standards Board Statement of
Financial Accounting Standards (“SFAS”) No. 128) "Earnings by Share" by dividing
income available to common stockholders by weighted average number of common
shares outstanding for each period.


6


Use
of Estimates





The
preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenue and expenses during the reported
period.  Actual results can differ from those estimates.





Revenue
Recognition





The
Company currently has no revenue.





NOTE
C - GOING CONCERN





The
Company's financial statements have been presented on the basis that it is a
going concern, which contemplates the realization of assets and the satisfaction
of liabilities in the normal course of business.  The Company has
reported net losses for the period from date of inception (June 17, 2009)
through December 31, 2009.





The
Company's continued existence is dependent upon its ability to raise capital or
to successfully market and sell its products.  The Company plans to
raise working capital through equity offerings and future profitable
operations.  The financial statements do not include any adjustments
that might be necessary should the Company be unable to continue as a going
concern.





NOTE
D – SUBSEQUENT EVENTS





Subsequent
events were evaluated through February 16, 2010, the date these financial
statements were issued.


7


MANAGEMENT’S
DISCUSSION AND ANALYSIS AND PLAN OF OPERATION





Forward-Looking
Statements: No Assurances Intended





In
addition to historical information, this Quarterly Report contains
forward-looking statements, which are generally identifiable by use of the words
“believes,” “expects,” “intends,” “anticipates,” “plans to,” “estimates,”
“projects,” or similar expressions. These forward-looking statements represent
Management’s belief as to the future of InoLife Technologies, Inc. (Formerly
NexxNow, Inc.)  Whether those beliefs become reality will depend on
many factors that are not under Management’s control.  Many risks and
uncertainties exist that could cause actual results to differ materially from
those reflected in these forward-looking statements. Readers are cautioned not
to place undue reliance on these forward-looking statements. We undertake no
obligation to revise or publicly release the results of any revision to these
forward-looking statements.





Results of Operations





Due to our lack of funds, our
operations are very limited.  As a result, we realized no revenue
during the three months ended December 31, 2009.





Our
largest expense was consulting services, which totaled $ 240,000 in the recent
period and $ 257,600 during the period from inception to December 31, 2009. We
realized a net loss of $ 258,860 for the three months ended December 31,
2009.  During the period from inception to December 31, 2009, we
realized an accumulated deficit of $1,038,050, primarily due to the $759,590
loss from recapitalization.





Liquidity and Capital
Resources





Since we initiated our business
operations in 2009, our operations have been funded primarily by the private
sale of equity and debt to investors.  During the three months ended
December 31, 2009, our operations were funded by financing and loans from
shareholders in the amount of $ 98,535.  Through December 31, 2009,
however, we had used virtually all of those funds for our
operations.





We
currently have very little cash on hand and no other liquid
assets.  Therefore, in order to carry on our business, we must obtain
additional capital.


We
continue to actively seek investment capital.  At the present time,
however, we have had limited commitments from funders to provide us any
additional funds.


8


Off-Balance
Sheet Arrangements





We do not
have any off-balance sheet arrangements that have or are reasonably likely to
have a current or future effect on our financial condition or results of
operations.





Impact
of Accounting Pronouncements





There
were no recent accounting pronouncements that have had a material effect on the
Company’s financial position or results of operations.  There were no
recent accounting pronouncements that are likely to have a material effect on
the Company’s financial position or results of operations.





Plan
of Operation





The plan
of operation of InoLife Technologies, Inc. (the “Company”) for the next twelve
months is centered around two main goals. First, based upon the Company’s recent
acquisition of InoVet, Ltd.(“InoVet”), the Company intends to focus upon
developing and implementing business opportunities based upon the body of
research already accomplished by InoVet in the area of developing and
introducing new treatments and support services that help prevent and treat
cancer in companion animals. As such, a prime goal of the Company is to be
active in the further development of Bone Marrow Transplantation and other
cancer treatment procedures to benefit companion animals (dogs and cats) that
are diagnosed with lymphoma, other types of cancers, and other diseases that are
currently incurable. As part of its plan, the Company will seek to identify and
establish formal working relationships and partnerships with some of the top
Veterinary Oncologists and Veterinary Cancer Researchers in the United
States. Second,
the Company currently intends to identify, develop and market multi-faceted,
human diagnostic product lines marketed towards both potential professional
medical and retail customers.  Based upon the Company’s recent execution of
a Strategic Alliance Agreement with InoHealth, Inc., the Company currently
anticipates that at least some of these product lines will revolve around
genetic DNA testing.





The
Company currently has limited financial resources available. The Company's
continued existence is strongly dependent upon its ability to raise capital and
to successfully develop, market and sell its products.  The Company
plans to raise working capital through equity and/or debt offerings and future
profitable operations.  However, the Company does not presently have
any assurances that such additional capital is, or will be
available.  There is a limited financial history of operations from
which to evaluate our future prospects, including our ability to develop a wide
base of customers for our products and services. We may encounter unanticipated
problems, expenses and delays in marketing our products and services and
securing additional customers. If we are not successful in developing a broad
enough market for our products and services, our ability to generate sufficient
revenue to sustain our operations would be adversely affected.


9


ITEM
3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK





Not
applicable.





ITEM
4.  CONTROLS AND PROCEDURES





Gary
Berthold, our Chief Executive Officer and Chief Financial Officer, carried out
an evaluation of the effectiveness of InoLife Technologies, Inc.’s (Formerly
NexxNow) disclosure controls and procedures as of December 31,
2009.  Pursuant to Rule13a-15(e) promulgated by the Securities and
Exchange Commission pursuant to the Securities Exchange Act of 1934, “disclosure
controls and procedures” means controls
and other procedures that are designed to insure that information required to be
disclosed by InoLife Technologies, Inc. (Formerly NexxNow) in the reports that
it files with the Securities and Exchange Commission is recorded, processed,
summarized and reported within the time limits specified in the Commission’s
rules.  “Disclosure
controls and procedures” include, without
limitation, controls and procedures designed to insure that information InoLife
Technologies, Inc. (Formerly NexxNow) is required to disclose in the reports it
files with the Commission is accumulated and communicated to our Chief Executive
Officer and Chief Financial Officer as appropriate to allow timely decisions
regarding required disclosure.  In the course of that review, Mr.
Berthold identified a material weakness (as defined in Public Company Accounting
Oversight Board Standard No. 2) in our internal control over financial
reporting.





The
material weakness consisted of inadequate staffing and supervision within the
bookkeeping and accounting operations of our company.  The relatively
small number of employees who have bookkeeping and accounting functions prevents
us from segregating duties within our internal control system.  The
inadequate segregation of duties is a weakness because it could lead to the
untimely identification and resolution of accounting and disclosure matters or
could lead to a failure to perform timely and effective reviews.  In
light of this situation, management has considered adding personnel to the
company’s
bookkeeping and accounting operations.  However, as there has been no
instance during fiscal 2009 or fiscal 2010 in which the company failed to
identify or resolve a disclosure matter or failed to perform a timely and
effective review, management determined that the addition of personnel to our
bookkeeping and accounting operations is not an efficient use of our limited
resources at this time.





Based on
his evaluation, Mr. Berthold concluded that InoLife Technologies, Inc.’s
(Formerly NexxNow) system of disclosure controls and procedures was not
effective as of December 31, 2009 for the purposes described in this
paragraph.





Changes in Internal
Controls.  There was no change in internal controls over
financial reporting (as defined in Rule 13a-15(f) promulgated under the
Securities Exchange Act or 1934) identified in connection with the evaluation
described in the preceding paragraph that occurred during InoLife Technologies,
Inc.’s (Formerly NexxNow) first fiscal quarter that has materially affected or
is reasonably likely to materially affect InoLife Technologies, Inc.’s (Formerly
NexxNow) internal control over financial reporting.


10





This
report does not include an attestation report of the Company’s registered public
accounting firm regarding internal control over financial
reporting.  Management’s report was not subject to attestation by the
Company’s registered public accounting firm pursuant to temporary rules of the
Securities and Exchange Commission that permit the Company to provide only
management’s report in this report.





PART
II   -   OTHER INFORMATION





Item
1.  Legal Proceedings.





None





Item
2.  Unregistered Sales of Equity Securities and Use of
Proceeds.





On
November 20, 2009 the Company sold $55,000 of its 12% Convertible Debentures to
an accredited investor. The Investor can convert the principal and accrued but
unpaid interest of the debenture into shares of the Company’s common stock. The
Conversion Price per share is 75% of the lowest closing price for the Company’s
stock during the 20 trading days prior to notice of conversion from the
Investor.





Item
3.  Defaults Upon Senior Securities.





None





Item
4.  Submission of Matters to a Vote of Security Holders.





None





Item
5.  Other Information.





During
the quarter the Company canceled its agreements with New York Consulting Group
and requested the return of 14 million shares issued to New York Consulting
Group and its designees. 7 million shares have been returned to the Company.
However, subsequently, after the end of the quarter, the Company discovered that
New York Consulting Group had filed a claim in arbitration with the American
Arbitration Association. New York Consulting Group has not provided the Company
with a copy its arbitration claim. The Company intends to vigorously defend any
claim but cannot predict the outcome of any proceeding.





Item
6. Exhibits





31.1 Rule
13a-14(a) Certification – CEO


31.2 Rule
13a-14(a) Certification – CFO


32 Rule
13a-14(b) Certification


11


SIGNATURES





Pursuant
to the  requirements  of the Securities  Exchange
Act of 1934, the Registrant  has
duly  caused  this  Report  to
be  signed  on its  behalf by the undersigned
thereunto duly authorized.





INOLIFE
      TECHNOLOGIES, INC.Date:
      February 16, 2010
              
              By:
              /s/
      Gary BertholdGary Berthold, Chief
      Executive
Officer


12